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A poliovirus type I (Mahoney strain) mutant was obtained by inserting three base pairs into an infectious 
eDNA clone. The extra amino acid encoded by the insertion was in the amino-terminal (protein 8) portion of 
the P2 segment of the polyprotein. The mutant virus makes small plaques on HeLa and monkey kidney (CV-1) 
cells at all temperatures. It lost the ability to mediate the selective inhibition of host cell translation which 
ordinarily occurs in the first few hours after infection. As an apparent consequence, the mutant synthesizes far 
less protein than does wild-type virus. In mutant-infected CV-1 cells enough protein was produced to permit 
a normal course of RNA replication, but the yield of progeny virus was very low. In mutant-infected He La cells 
there was a premature cessation of both cellular and viral protein synthesis followed by a premature halt of 
viral RNA synthesis. This nonspecific translational inhibition was distinguishable from wild-type-mediated 
inhibition and did not appear to be part of an interferon or heat shock response. Because the mutant is 
recessive, our results imply that (at least in HeLa cells) wild-type poliovirus not only actively inhibits translation 
of cellular mRNAs, but also avoids early inhibition of its own protein synthesis. Cleavage of the cap-binding 
complex protein P220, which has been associated with the selective inhibition of capped mRNA translation, did 
not occur in mutant-infected cells. This result supports the hypothesis that cleavage of P220 plays an important 
role in normal poliovirus-mediated translational inhibition. 
-------~--- ------~-~---·· 
It has long been recognized that infection of cells with 
poliovirus results in a selective inhibition of host cell protein 
synthesis (for a review, see reference 2). Translation of 
cellular mRNA steadily declines as virus-specific translation 
increases; by 2 to 3 h after infection viral RNA. which unlike 
most other translated eucaryotic RNAs lacks a 5' m7Gp-
ppN(m) cap structure (8, 28), is translated almost exclu-
sively. Presumably, a viral product mediates this inhibition, 
but it has not been identified. 
Results of early studies have shown that translation of 
cellular mRNA is blocked at the initiation step (19). More 
specifically, the defective initiation factor appears to be a 
salt-stable complex composed of a cap-binding protein 
(CBP) and associated proteins. This complex is thought to be 
crucial for the attachment of capped mRNAs to 40S ribo-
somal subunits (for a review, see reference 37). Infected cell 
extracts do not support the translation of capped RNAs (7, 
34) or their attachment to the CBP complex (16), but both 
activities can be restored by the addition of CBP complex 
from uninfected cells (17, 41). In vivo, the decline in host 
protein synthesis is preceded by specific cleavage of a 
220,000-dalton protein (P220) which is part of the CBP 
complex (6). It has been proposed that the complex is 
inactivated by this cleavage (6). A viral product is thought to 
carry out or promote the cleavage of P220, but the known 
viral protease (protein 7c) is probably not involved (18. 23). 
Until recently it has been difficult to apply genetics to the 
study of poliovirus. Mutants have been obtained by treating 
infected cells with chemical mutagens (for a review, see 
reference 4), but these mutants contain lesions which are 
difficult to map. Moreover, it is not known that they contain 
only one lesion or that a particular lesion is responsible for 
an observed phenotype. The construction of a full-length 
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eDNA clone of poliovirus which yields infectious virus when 
transfected on HeLa or monkey kidney cells (33) has made it 
possible to construct well-defined viral mutants. Here we 
show that one such mutant, which has an extra amino acid in 
the protein 8 region of the polyprotein, is defective in the 
host translational inhibition function. We found an unsus-
pected decline of all protein synthesis in place of the normal 
shift to virus-specific translation in mutant-infected HeLa 
cells. In addition. we found that P220 is not cleaved in cells 
infected by this mutant. 
MATERIALS AND METHODS 
DNA procedures. Plasmid pSV2-polio was obtained from 
V. Racaniello. Restriction endonucleases and T4 DNA ligase 
were purchased from New England BioLabs, Inc., Beverley, 
Mass.; DNA polymerase I (Klenow fragment) was purchased 
from Boehringer Mannheim Biochemicals, Indianapolis, Ind. 
These enzymes were used according to the manufacturer's 
instructions. The modified calcium phosphate method of 
transfection was used in the experiments described here (30). 
Cells and virus stocks. CV-1 cells (African green monkey 
kidney cells) were maintained in Dulbecco modified Eagle 
medium (DME) supplemented with 10% fetal calf serum 
(Hazleton). HeLa cells were grown in suspension in the 
Joklik modification of minimal essential medium (MEM) 
supplemented with 7% horse serum (GIBCO Diagnostics, 
Madison, Wis.). 
The wild-type virus stock used in all experiments was 
made by isolating a single plaque from a pSV2-polio trans-
fection and expanding it on HeLa cells by conventional 
means. Mutant HF121 stocks were obtained as follows. 
CV-1 cells seeded in 100-mm petri dishes were transfected 
with mutant DNA and incubated at 37°C in DME supple-
mented with 5% fetal calf serum for 5 to 6 days. At that time 
the remaining cells were scraped into the medium. These 
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FIG. 1. (A) Strategy for generating mutants. pSV2-polio, a derivative of the mammalian expression vector pSV2 (26) which contains an 
infectious type I (Mahoney strain) poliovirus eDNA insert, was used in all mutagenesis experiments. The plasmid was first partially digested 
with the restriction endonuclease Hinfl to maximize the yield of molecules cleaved randomly at only 1 of the 43 recognition sequences in the 
plasmid. Linear molecules were purified by agarose gel electrophoresis. The 3' ends were then filled in with DNA polymerase (Klenow 
fragment) and deoxynucleoside triphosphates. The DNA was recircularized with T4 DNA ligase and used to transform Escherichia coli 
88101. The resulting plasmids (pSV2-polio') were then screened for the loss of single Hinfl restriction sites. Abbreviations: bp, base pairs; 
kb, kilobases; SV40, simian virus 40. (8) Sequence of mutant HF121. Restriction digest analysis revealed that HF121 had lost the Hinfl site 
at position 3690 of the poliovirus eDNA insert. The BstEII fragment between positions 3235 and 3925 was then exchanged with the equivalent 
wild-type fragment and shown to carry the mutant phenotype. This fragment was sequenced by the method of Maxam and Gilbert (24) and 
shown to be identical to the wild-type sequence (14, 32) except for the expected insertion. The mutant contains an extra leucine in P2-3b, and 
its cleavage product protein 8 as shown. 
transfection stocks, which contained virus from many infec-
tious centers, were frozen and thawed three times and then 
passaged once on fresh CV-1 cells. In this passage the cells 
were scraped into a small volume at 12 h postinfection and 
frozen and thawed three times. This procedure yielded virus 
stocks which were relatively free of wild-type variants and 
which had a sufficient titer with which to perform experi-
ments. 
Virus infections. For CV-1 infections, 60-mm petri dishes 
containing 3 x lOS to 5 x lOS cells were used, except in one 
experiment, in which 100-mm petri dishes containing 1.5 x 
106 cells were used. The dishes were washed once, and virus 
was added at the appropriate multiplicity of infection (MOl) 
in 200 !J.l of DME (or 400 tJ.l for 100-mm dishes). The virus 
was uniformly distributed over each plate, and the cells were 
incubated at 37°C for 30 min to allow the virus to adsorb~ 
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FIG. 2. Phenotype of mutant HF121. Wild-type and mutant virus 
stocks were prepared as described in the text. Mutant phenotype 
was defined by a plaque assay with monolayer CV-1 cells or HeLa 
cells plated from suspension shortly before inoculation. The plates 
were inoculated with wild-type or mutant virus and incubated at 
37°C for approximately 40 and 65 h, respectively, and then stained. 
(A) Wild-type on CV-1 monolayer; (B) mutant on CV-1 monolayer; 
(C) wild-type on HeLa monolayer; (D) mutant on HeLa monolayer. 
during this incubation the plates were shaken periodically to 
facilitate adsorption. DME supplemented with 5% fetal calf 
serum was then added (1.5 ml, or 2.5 ml for 100-mm dishes), 
and the dishes were placed at 37oC for the duration of the 
experiment. 
For HeLa infections, cells were collected by centrifuga-
tion and washed once. The cells were then suspended in as 
small a volume as possible of MEM containing virus (usually 
no more than 50 to 100 J.LI per 3 x 106 cells). The virus was 
allowed to adsorb for 30 min at room temperature; during 
this time the tubes were shaken periodically to facilitate 
adsorption. The cells were then diluted in MEM supple-
mented with 5% fetal calf serum and 10 mM N-2-
hydroxyethylpiperazine-N' -2-ethanesulfonic acid (pH 7 .2) to 
a concentration of 3 x 106 per ml and stirred with a small 
magnetic bar in a 37°C water bath. 
In both CV-1 and HeLa experiments in which production 
of progeny virus was measured, the cells were washed after 
adsorption and then medium was added. 
Measurement of viral RNA synthesis. Actinomycin D (5 
J.Lg/ml), a gift from Merck Sharp & Dohme, West Point, Pa., 
was added to cells at 15 min postinfection, and [14C]uridine 
(0.5 J.LCi/ml), purchased from New England Nuclear Corp. , 
Boston, Mass. (>350 mCi/mmol), was added at 2 h postin-
fection. At appropriate times duplicate dishes of CV-1 cells 
were placed on ice. The medium was replaced with cold 5% 
trichloroacetic acid (TCA), into which the cells were 
scraped. In other experiments, duplicate 100-,.LI fractions of 
HeLa cells (3 x 105 cells) were added directly to 1 ml of cold 
5% TCA. The precipitates were collected on Millipore 
filters , which were dissolved in Bray Solution (New England 
Nuclear) and counted. Poliovirus RNA synthesis was mea-
sured as TCA-precipitable counts in the presence of 
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actinomycin D. Incorporation in actinomycin D-treated 
mock-infected cells was subtracted as background. 
Cell extracts and electrophoretic analysis. Petri dishes 
containing CV -1 cells were first washed in phosphate-
buffered saline (PBS). The cells were then scraped into PBS, 
collected by centrifugation, and lysed in phospholysis buffer 
(1% Triton X-100, 0.5% sodium deoxycholate, 0.1% sodium 
dodecyl sulfate [SDS], 1 mM phenylmethylsulfonyl fluoride 
in PBS) at a concentration of 107 cells per mi. HeLa cells 
were washed twice in PBS and then lysed in phospholysis 
buffer at the same concentration. Chromatin was removed 
by centrifugation in a microfuge, and the supernatants were 
frozen. 
SDS-polyacrylamide gel electrophoresis was performed 
essentially by the method of Laemmli (15), except that in 
some cases lower ratios of monomer to cross-linker were 
used in the separating gels. Gels were stained with Coomas-
sie blue, fluorographed, dried, and autoradiographed at 
-70°C. Immunological detection of specific proteins was 
performed by transferring the resolved proteins to nitrocel-
lulose by electroelution and probing with antisera essentially 
as described previously (42). In these experiments antigen-
antibody complexes were detected with 125I-Iabeled protein 
A (New England Nuclear). 
Antisera. A polyclonal antiserum against protein X was 
obtained by immunizing rabbits with partially purified pro-
tein X preparations from poliovirus-infected HeLa cells (P. 
Zabel and D. Baltimore, unpublished data). The polyclonal 
antiserum against cellular protein P220 has been described 
previously (17). 
RESULTS 
Construction and mapping of small-plaque mutant HF121. 
Racaniello and Baltimore (33) have inserted the full-length 
poliovirus type I eDNA into a derivative of the mammalian 
expression vector pSV2-gpt (26; Fig. 1A). This plasmid 
yields far more infectious centers on transfection than the 
original pBR322 derivative (P. Sarnow and D. Baltimore, 
unpublished data). We obtained from this clone (designated 
pSV2-polio) a series of single-codon insertion mutants. The 
mutagenesis scheme involved random linearization of the 
plasmid with restriction enzymes which generate three-base 
overhangs, filling in with DNA polymerase, and reclosing 
with DNA ligase (Fig. 1A). By assaying for the loss of 
restriction sites, we were able to map these mutants (H. 
Bernstein and D. Baltimore, unpublished data). One mutant 
contained an extra amino acid in the amino terminal (protein 
8) region of the P2 segment of the poliovirus polyprotein 
(Fig. 1B). When this mutant (designated HF121) was 
transfected onto He La or CV -1 cells and infectious centers 
were scored by plaque assay, virtually all the plaques were 
minute relative to the wild type. Virus stocks prepared from 
cells transfected with HF121 also yielded minute plaques on 
these and other strains of human and monkey kidney cells 
(Fig. 2). Whereas wild-type plaques were easily scored after 
36 h, mutant plaques were clearly visible only after 60 h; 
even at this time the plaques were often still pinpoint in size. 
To examine whether the amino acid inserted in the protein 8 
region was responsible for the phenotype of the mutant, 
rather than an accidental second alteration in the DNA, we 
exchanged the BstEII fragment of HF121 which contained 
the insertion (Fig. 1B) with the equivalent fragment of 
wild-type DNA. Only those clones which contain the altered 
Bst Ell fragment gave rise to the mutant phenotype. In 
addition, the only sequence difference found between mu-
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FIG . 3. Time course of RNA synthesis, progeny virus production, and appearance of cytopathic effect (CPE) in mutant- and 
wild-type-infected CV-1 cells . (A) CV-1 cells were infected at an MOl of 5. Wild-type (e) or mutant (0 ) RNA synthesis was measured as 
[ 14C]uridine incorporation into TCA-precipitable material in the presence of actinomycin D. Wild-type (A) or mutant (6) progeny virus 
production was measured as the titer of recovered virus. Cells were placed on ice at various times postinfection and scraped into the medium. 
After three freeze-thaw cycles titers of these stocks were determined by plaque assay . Cytopathic effect was scored as follows : - , little or 
no detectable rounding up of cells: +. cells clearly elongated or partially rounded up; + +, cells ready to detach from substrate, floating in 
suspension, or lysed . (B) CV-1 cells were infected and treated as described above for panel A. Total cytoplasmic RNA was purified from cells 
harvested at 5 h postinfection and analyzed by electrophoresis essentially as described previously (9). RNA from approximately 10" cells was 
loaded in each track. Agarose gels were stained with ethidium bromide, dried, and autoradiographed at -70°C. Lane 1, mutant (M) RNA ; lane 
2, wild-type (WT) RNA. Abbreviations: ds , double stranded; ss, single stranded. 
tant and wild-type eDNA was the three-base-pair insertion at 
the expected site (the sequence is shown in Fig. 1B). 
Growth of HF121 in a single cycle of infection. To obtain an 
approximate idea of the nature of the defect in HF121, we 
first examined the ability of the mutant to produce infectious 
progeny virus in a single cycle of infection. In wild-type-
infected cells , virion assembly begins at about 3 h postinfec-
tion and lasts until 5 to 6 h postinfection. By the time normal 
virus production ceased, mutant-infected CV-1 cells had 
accumulated 50- to 100-fold fewer plaque-forming particles 
(Fig. 3A); the discrepancy was at least as great in HeLa cells 
(data not shown) . The number of SDS-stable 150S virion 
particles produced was also reduced to approximately the 
same extent (data not shown). Hence the small-plaque 
phenotype of HF121 was at least partially due to a low yield 
of progeny virus. Between 6 and 24 h the titer slowly 
increased in CV-1 cells (Fig. 3A). 
We also examined the ability of HF121 to induce the 
dramatic morphological changes in adherent cells (the 
cytopathic effect) which normally precede cell death (for a 
review, see reference 1). Most wild-type-infected CV -1 cells 
began to pull away from the tissue culture dish by 4 h 
postinfection; between 5 and 6 h postinfection all of the cells 
rounded up and detached (Fig. 3A). At 6 h postinfection, 
however, HF121-infected CV-1 cells showed no signs of 
pulling away from the substrate. Cytopathic effect developed 
gradually (Fig. 3A) but much more heterogeneously than in 
a population of wild-type-infected cells. This heterogeneity 
in the development of the cytopathic effect may partially 
explain the observation that HF121 plaques are often ragged 
and ill defined. The small-plaque phenotype of the mutant 
thus can be explained by both the dramatic reduction in virus 
production and the prolongation of each cycle of infection. 
RNA synthesis in mutant-infected cells. To further charac-
terize the HF121 defect, we examined the ability of the 
mutant to replicate its genome . In CV-1 cells, HF121 syn-
thesized RNA at the same rate and in the same quantity as 
wild-type virus (Fig. 3A). Moreover, the ratio of full-length, 
single-stranded RNA to double-stranded RNA which accu-
mulated during the course of infection was the same as that 
seen during infection with wild-type virus (Fig. 3B). In HeLa 
cells, by contrast, mutant RNA synthesis began normally 
but tapered off at about 3.5 h postinfection and reached an 
early plateau. As a result the mutant made less than 20% as 
much RNA as wild-type virus (Fig. 4A). Furthermore, 
HF121-infected HeLa cells accumulated excess double-
stranded RNA (Fig. 4B). This phenomenon was most evi-
dent at about 3 h postinfection, when double-stranded RNA 
was far more abundant in mutant than in wild-type-infected 
cells (Fig. 4B, lanes 1 and 2). Results of these experiments 
indicate that the physiology of the mutant is host cell 
dependent and suggest that the defect involves virus-host 
interactions . 
Apparent revertants of HF121 obtained after passage on 
CV-1 cells also had wild-type growth properties on HeLa 
cells; such variants obtained after passage on HeLa cells 
also behaved like wild-type virus on CV-1 cells (data not 
shown). Because HF121 contains a single amino acid inser-
tion, these variants very likely were produced by second-site 
suppressor mutations. The observation that suppression of 
the mutation in one cell type also suppresses the mutation in 
the other cell type implies that the lesion probably does not 
cause multiple defects in protein structure which account for 
the host-dependent behavior of the mutant. 
Translation of host mRNA and viral RNA in mutant-
infected cells. Under the conditions used in this study, 
wild-type poliovirus almost completely inhibits host cell 
translation in CV-1 cells by 3 h postinfection. When whole 
cell extracts of cells pulse-labeled at this time with 
[35S]methionine were analyzed by SDS-polyacrylamide gel 
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FIG. 4. Time course of RNA synthesis in mutant- and wild-type-
infected HeLa cells. (A) HeLa cells were infected at an MOl of 5. 
Wild-type (e) or mutant (0) RNA synthesis was measured as 
[14C]uridine incorporation into TCA-precipitable material in the 
presence of actinomycin D. (B) HeLa cells were infected and treated 
as described above for panel A. Total cytoplasmic RNA was purified 
from cells harvested at 3 h (lanes 1 and 2) or 4 h (lanes 3 and 4) 
postinfection. RNA purification and agarose gel electrophoresis 
were as described in the legend to Fig. 38. RNA from approximately 
1.5 x 106 cells was loaded in lanes 1 through 3; one-third as much 
was loaded in lane 4. Lanes 1 and 3, mutant (M) RNA; l<)nes 2 and 
4, wild-type (WT) RNA. Abbreviations: ds, double stranded; ss, 
single stranded. 
electrophon:sis, the only labeled proteins were virus specific 
(Fig. 5A, lane 7). By contrast, only host cell proteins were 
labeled in [35S]methionine pulse-labeled extracts of mutant-
infected cells (Fig. 5A, lane 6). Analysis of the electropho-
retically fractionated proteins with antibody probes revealed 
that a detectable, but greatly reduced, amount of virus-
specific protein was synthesized at this time (Fig. 5B, lane 
3). Thus, HF121 appears to have a defect in the function 
which inhibits host cell translation. Little viral protein can be 
made in cells infected by this mutant, presumably because 
the viral RNA molecules must compete with a large excess 
of cellular mRNA for attachment to ribosomes. At 4 and 5 h 
postinfection, most of the protein that was synthesized was 
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still host cell specific (Fig. 5A, lanes 9 and 12). As the 
number of HF121 RNA molecules increased with replica-
tion, however, the amount of virus-specific translation also 
increased; in the later [35S]methionine pulse-labeled ex-
tracts, poliovirus proteins 1b and 2 were clearly labeled (Fig . 
SA, lanes 9, 12, 15, and 17). The other viral proteins were 
also synthesized (Fig. 58) but were not visible in the 
background of cellular protein synthesis. Even at these later 
times, though, the amount of viral protein which was syn-
thesized was only a small fraction of that produced in 
wild-type-infected cells. Synthesis of virus-specific proteins 
was never predominant, as it was during wild-type infection. 
After the shift from host mRNA translation to viral RNA 
translation occurred in wild-type-infected CV -1 cells, virus-
specific proteins were made continuously until about 5 h 
postinfection (Fig. 5A, lanes 7, 10, and 13). Although in-
fected cells exhibit morphological and biochemical alter-
ations which become increasingly dramatic, it is not clear 
why translation declines late in infection (40). Also, by 5 h 
postinfection, inhibition of protein synthesis was clearly 
observable in HF121-infected cells, although it was much 
less marked than in wild-type-infected cells. By 7 to 8 h 
postinfection the rate of translation declined to less than 20% 
of the level seen in control cells (Fig. 5A, lanes 15 and 17). 
There was apparently no specificity involved in this inhibi-
tion; what viral translation was occurring was inhibited to 
the same degree as cellular translation. 
In He La cells, as in CV -1 cells, the mutant did not effect 
a shift from host protein synthesis to virus-specific synthesis 
(Fig. 6). This shift was evident at 2 h postinfection and was 
complete by 3 h in a wild-type infection. In mutant-infected 
cells, however, there was a global inhibition of protein 
synthesis which began at 2 h and became very marked by 4 
h postinfection (Fig. 6, lanes 5, 8, and 11), during a period 
when virus-specific translation was at its height in wild-type-
infected cells. Presumably because the copy number of 
mutant RNA molecules is relatively low when the inhibition 
occurs, virus-specific proteins were detectable only with 
antibody probes (data not shown). As in CV-1 cells, trans-
lation of both cellular RNAs and poliovirus RNA was 
similarly affected by the mutant-induced inhibition, but, 
whereas global inhibition of protein synthesis became evi-
dent after RNA synthesis was complete in CV-1 cells, it 
occurred in HeLa cells at a time when the linear phase of 
RNA synthesis was just beginning. This early cessation of 
protein synthesis paralleled and may explain the observed 
decline in RNA synthesis. Experiments with inhibitors of 
protein synthesis such as puromycin have shown that inhi-
bition of translation leads to a gradual shutdown in viral 
RNA synthesis (35). 
We can further distinguish the nonspecific mutant-induced 
inhibition of translation in both CV -1 and He La cells from 
normal poliovirus-induced host iQhibition. It has been shown 
that 1 mM guanidine hydrochloride specifically blocks viral 
replication but permits synthesis of viral protein and does 
not affect cellular metabolism (for a review, see reference 2). 
When this inhibitor was added at 3 h postinfection to 
mutant-infected CV-1 cells, at a time when wild-type-
mediated translational inhibition was complete, the mutant 
did not induce a translational decline (Fig. 7A). When 
guanidine was added at the time of infection of HeLa cells, 
wild-type virus was still able to depress host cell translation 
relatively well, but the mutant did not induce translational 
inhibition (Fig. 7B). Apparently, as suggested by results of 
previous studies (31), input wild-type RNA molecules that 
are prevented from undergoing replication by guanidine are 
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FIG. 5. Pattern of protein synthesis in mock- , mutant- (M). and wild-type (WT)-infected CV-1 cells at various times after infection. (A) 
CV-1 cells were infected at an MOl of 10. At various times after infection, medium was removed from appropriate dishes and replaced with 
methionine-free DME containing 5% dialyzed fetal calf serum. [35S]methionine (>800 Ci/mmol: New England Nuclear) was added to a final 
concentration of 50 f.I.Ci/ml. Cells were incubated at 37°C for 10 min and then placed immediately on ice . Cell extracts were made as described 
in the text. A portion (25 f.l.ll of each extract was analyzed by electrophoresis through a 15% SDS-polyacrylamide-0.09% N ,N'-
methylenebisacrylamide gel. Lanes 1, 3, 5, 8, 11, 14, and 16, mock-infected extracts(-): lanes 6. 9. 12. 15, and 17, mutant-infected extracts 
(M); lanes 2, 4, 7, 10, and 13. wild-type-infected extracts (WT). (8) Portions (25 f.l.ll ofCV-1 extracts shown in panel A were resolved on a 
15% SDS-polyacrylamide-0.09% N,N'-methylenebisacrylamide gel, and the resolved proteins were then transferred to nitrocellulose. The 
filter was probed with a polyclonal antiserum against poliovirus protein X. (As shown above, this serum also contains some activity against 
poliovirus proteins that contain p63 sequences, including p63, lb. and 2. Lane 1. wild-type-infected extract (WT) at 3 h postinfection; lane 
2, mock-infected extract at 8 h postinfection; lanes 3 through 6, mutant-infected extracts at 3. 5, 7, and 8 h postinfection. 
able to direct synthesis of sufficient amounts of protein to 
cause an inhibition of host cell translation. By contrast, the 
mutant-induced global inhibition of protein synthesis must 
require extensive accumulation of viral products and cannot 
be produced by input RNA. 
The nonspecific mutant-induced translational inhibition 
does not appear to be identical to previously identified 
cellular responses to viral infection. Because the inhibition 
occurred even when actinomycin D was added prior to or at 
the time of HF121 infection (data not shown), it did not 
involve the production of new cellular transcripts . Results of 
this experiment rule out the possibility that it was the result 
of a cellular response to interferon treatment or a conse-
quence of interferon induction. Actinomycin D blocks the 
effects of interferon; these include sharp elevation of the 
level of a double-stranded, RNA-dependent protein kinase 
which is thought to inhibit protein synthesis by phos-
phorylating the a-subunit of eucaryotic initiation factor 2 
(13, 20). No new major cellular proteins were synthesized 
after the onset of the mutant-induced inhibition (Fig. SA and 
6); in this respect HF121-infected cells did not appear to 
undergo the typical stress response induced by exposure to 
elevated temperatures or toxic substances (for a review, see 
reference 36). 
Fate of the CBP complex protein P220 in HF121-infected 
cells. As described above, poliovirus-induced translational 
inhibition has been correlated with characteristic cleavage of 
the CBP complex protein P220. We examined whether this 
protein was cleaved in mutant-infected cells by probing 
electrophoretically fractionated proteins from those cells 
with an antiserum raised against P220. As has been shown 
previously (17, 18), the specific cleavage products of P220, 
which migrate at -120,000 daltons, give a stronger signal in 
this type of analysis than does the uncleaved protein. The 
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FIG. 6. Pattern of protein synthesis in mock-. mutant-. and 
wild-type-infected HeLa cells at 1-4 hours after infection. HeLa 
cells were infected at an MOl of 10. At 1. 2. 3. and 4 h after 
infection. 1.5 x 106 cells from each culture were collected by 
centrifugation and suspended in methionine-free DME containing 
5% dialyzed fetal calf serum. [35S]methionine was added to a final 
concentration of 50 ILCi/ml. Cells were stirred at 37"C for 10 min and 
then placed immediately on ice . Cell extracts were made as de-
scribed in the text. A portion (30 ILl) of each extract was analyzed by 
electrophoresis through a 15'/C SDS-polyacrylamide-0.09'/C N.N'-
methylenebisacrylamide gel. Lanes 1. 4. 7, and 10. mock-infected 
extracts(-); lanes 2. 5, 8. and 11. mutant-infected extracts (M): 
lanes 3. 6, 9, and 12. wild-type-infected extracts <WT). 
signal discrepancy appears to be particularly large with CV-1 
cell extracts. As a result, the most reliable indication of the 
fate of P220 in these cells is the level of cleavage products. In 
wild-type-infected CV -1 cells, P220 cleavage products were 
evident by 2 h postinfection (Fig. 8A. lane 4). In mutant-
infected CV-1 cells, by contrast, significant levels of cleav-
age products were not evident; the small amount present 
only in Fig. 8A, lane 7 (5 h postinfection) is often found in 
mock-infected cells (Fig. 8A, lane 2: N. Sonenberg, unpub-
lished data). In the mutant-infected cells intact P220 was 
clearly detectable over the entire course of infection (Fig. 
8A, lanes 6 through 8), despite the marked decline in protein 
synthesis. In wild-type-infected HeLa cells. P220 was 
cleaved even more rapidly than in CV-1 cells: cleavage 
products were evident by 1 h postinfection , and by 2 h more 
extensive cleavage had occurred (Fig. 88, lanes 4 and 5). Yet 
in mutant-infected HeLa cells, even at 4 h postinfection, 
when translation was inhibited by > 80%, no cleavage prod-
ucts were evident (Fig. 8B , lanes 7 through 9) . In the 
mutant-infected cell s intact P220 was clearly present 
throughout the course of infection. To be sure that the 
absence of P220 cleavage was not due to a problem with the 
mutant infections, we monitored translation rates in both 
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CV-1 and HeLa experiments and found that they followed 
previously observed kinetics . These observations further 
support the hypothesis that poliovirus-mediated selective 
suppression of capped mRNA translation involves cleavage. 
and presumably therefore inactivation, of P220. 
DISCUSSION 
We used a eDNA copy of poliovirus type I to create a 
mutation in the protein 8 region of the viral genome. The 
resulting small-plaque mutant failed to selectively inhibit the 
translation of cellular mRNA in monkey kidney <CV-1) and 
human (HeLa) cells. As an apparent consequence, only a 
small fraction of the normal amount of viral protein was 
synthesized. In certain respects the behavior of the mutant 
was host cell dependent. It produced a full yield of RNA in 
CV-1 cells, but in HeLa cells there was a premature inhibi-
tion of all protein synthesis followed by an inhibition of viral 
RNA synthesis. In both cell types, infection with the mutant 
virus failed to elicit the cleavage of cellular protein P220. 
which is a component of the protein complex that facilitates 
the binding of the 5' cap on cellular mRNAs to 40S ribosomal 
subunits. The data imply that the protein 8 region encodes a 
function which either directly or indirectly causes cleavage 
of P220. Our experiments also provide genetic evidence in 
support of previous suggestions that cleavage of P220 is an 
integral part of the virally mediated inhibition of host cell 
translation. 
Virus-induced inhibition of host cell protein synthesis. The 
lesion in HF121 is located within the coding sequence for 
two poliovirus proteins. protein 8 and the larger protein 3b. 
One or the other is probably responsible for mediating host 
translational inhibition. However. we cannot completely 
rule out a long-range effect on the folding or cleavage of 
another part of the polyprotein which could affect a distant 
function. At a gross level the lesion does not prevent or alter 
the cleavage of P2 from the polyprotein or any of the 
cleavages within P2 (Fig. 58). Additional studies on the 
protein 8 region, and possibly construction of additional 
mutants, should help resolve this issue. 
Although cleavage of P220 appears to be an important part 
of translational inhibition, poliovirus may not act directly on 
that protein. Because cleavage products which comigrate 
with those seen after poliovirus infection can also appear in 
lesser amounts in uninfected cells. it might be suspected that 
the virus activates a normal cellular mechanism which is 
responsible for the turnover of P220. Protein 8 contains a 
sequence of over 20 amino acids. however. which is strik-
ingly similar to a portion of the known viral protease (protein 
7c). A comparison of this sequence to the National Biomed-
ical Research Foundation protein library with the program of 
Lipman and Pearson (22) reveals clear homology with a 
variety of known serine proteases. The aligned region of 
these proteases includes the highly conserved sequence 
GDSGG (27) which contains the active site serine. Curi-
ously. a cysteine is substituted for the serine in both 8 and 
7c. The insertion in mutant HF121 is located a few amino 
acids before the region of similarity between the two viral 
proteins. 
Cleavage of P220 may also be only a part of the process by 
which poliovirus inhibits host cell translation. Other events 
have been observed to occur soon after infection and in the 
absence of viral replication. These include extensive rear-
rangement of the cytoskeletal framework. with which trans-
lation initiation factors (3) and ribosomes (11) are associated. 
and dissociation of both ribosomes and mRNA from this 
matrix (21). It is not clear what. if any, role these events play 
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harvesting the cells in the way described for RNA synthesis experiments. Symbols: •. Mock-infected cells; 0, mock-infected cells and cells 
treated with guanidine; A, mutant-infected cells; f:J., mutant-infected cells and cells treated with guanidine. (8) HeLa cells were infected at 
an MOl of 15. After adsorption of the virus, each culture was suspended in medium and divided in half, and 1 mM guanidine hydrochloride 
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in translational inhibition or how they relate to cleavage of 
P220. 
Most other picomaviruses inhibit the translation of host 
cell proteins. Human rhinovirus 14, which is highly homol-
ogous to poliovirus at the amino acid level (including in the 
protein 8 region) (39), also mediates the cleavage of P220 in 
HeLa cells (5). Unlike poliovirus, however, encephalomyo-
carditis (EMC) virus does not appear to inactivate any 
translation initiation factors (12). For this reason it has been 
proposed that EMC virus and poliovirus utilize different 
mechanisms to effect translational inhibition (12). In accord 
with this proposal, evidence has recently been obtained that 
P220 is not cleaved in EMC virus-infected cells (25). Al-
though at the amino acid sequence level poliovirus (14, 32) is 
less related to EMC virus (29) than to human rhinovirus 14, 
its capsid, protease, polymerase, and X proteins are clearly 
homologous to the corresponding EMC virus proteins. 
Poliovirus protein 8, however, is not homologous to its EMC 
counterpart, protein G. Thus it might be imagined that the 
two proteins have different functions. At the very least, the 
assignment of the poliovirus translational inhibition function 
to a region of the polyprotein which has a different sequence 
in EMC virus is consistent with the notion that the two 
viruses effect translational inhibition in different ways. 
Consequences of the mutation in HF121. Although the 
single amino acid insertion in HF121 has complex conse-
quences for the virus, certain functions are unaffected by the 
mutation. These include viral RNA synthesis in monkey 
kidney cells and the formation of virions (in proportion to the 
reduction in titer) which have normal hydrodynamic proper-
ties, stability, and composition (data not shown). The other 
aspects of the HF121 infection cycle are best considered 
separately for the different host cells studied. 
The small amount of viral protein made in CV -1 cells in the 
absence of translational inhibition is sufficient for RNA 
synthesis but not for extensive particle formation. H~nce the 
virus has probably evolved the ability to selectively inhibit 
host cell protein synthesis primarily because a large amount 
of protein is requited to encapsidate viral RNA molecules. 
Each virion is formed from 60 copies of each capsid protein 
but only one RNA molecule. One copy of VPg (the 5'-
terminal protein on the RNA) and, possibly, no more than 
one copy of each protein involved in replication may be 
sufficient to form each RNA molecule. The small-plaque 
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mutant-infected cells at 2 to 4 h postinfection . 
phenotype of the mutant is largely explained by the low yield 
of progeny virus. The slow development of cytopathic effect 
and the delay of cell lysis may also be partly responsible, but 
these phenomena are probably secondary consequences of 
the reduction in viral protein synthesis or particle formation . 
In mutant-infected CV-1 cells there is a late inhibition of 
all protein synthesis . This global inhibition may be the same 
event which normally occurs at about 5 h postinfection and 
terminates viral RNA and protein synthesis. It may be part 
of a cellular response to the accumulation of viral products. 
The discovery of a premature inhibition of all protein syn-
thesis in mutant-infected HeLa cells, however, raises the 
possibility that this decline is a delayed version of an event 
that has no counterpart in wild-type-infected cells. 
Whatever the mechanism of the mutant-induced early 
translational inhibition in HeLa cells, it is clearly distinguish-
able from wild-type-induced inhibition on four counts . First, 
it is prevented by treatment with guanidine, whereas normal 
inhibition is not. Second, it is not correlated with a cleavage 
of P220. Third , it inhibits viral as well as host protein 
synthesis and therefore does not work selectively on capped 
mRNAs. Fourth, it is accompanied by a premature inhibition 
of viral RNA synthesis and a relative increase in the accu-
mulation of double-stranded RNA. (Excess double-stranded 
RNA synthesis also has been noted in cells treated with 
guanidine [2]) . Apparently continuous, though not necessar-
ily efficient, translation of poliovirus proteins is required for 
normal RNA synthesis. The global inhibition could be a 
normal cellular response to infection but is not obviously 
related to interferon or heat shock-induced responses. We 
are currently investigating whether this phenomenon never-
theless involves phosphorylation of eiF2 . Recently, the 
translational decline seen in He La cells infected by a VA I 
RNA deletion mutant of adenovirus has been reported to 
involve phosphorylation (by an as yet undetermined kinase) 
of this translation factor (38). 
There are two plausible explanations for the premature 
inhibition of translation in mutant-infected HeLa cells. The 
mutant may have lost a function which ordinarily blocks. or 
at least delays, the development of global translational 
decline. This could be either a second activity of the protein 
8/3b region or another aspect of the same activity that leads 
to P220 cleavage. Alternatively, it might be thought that the 
mutation in HF121 could generate a new viral function which 
effects an abnormal translational decline. This second pos-
sibility is unlikely because HF121 is a recessive mutant. It 
can be complemented in either HeLa or CV-1 cells by every 
other mutant tested so far. Mixed infections with the second 
mutant increases the titer of HF121 in a single cycle of 
infection by as much as 50- to 100-fold. Additionally, He La 
cells coinfected with HF121 and wild-type virus synthesize 
RNA normally (H. Bernstein and D. Baltimore, manuscript 
in preparation). Thus the implication of these results is that , 
at least in HeLa cells, wild-type poliovirus not only selec-
tively inhibits the synthesis of capped mRNAs but also has 
the ability to avoid the nonselective translational inhibition 
which occurs in HF121-infected cells. 
Poliovirus mutants made by manipulating DNA. One impli-
cation from these studies is that useful poliovirus mutants, 
and presumably mutants of other related plus-stranded vi-
ruses , can be made by manipulating infectious eDNA. 
HF121. the mutant described here. is one of three defective 
(yet viable) poliovirus mutants of a total of 24 generated by 
the strategy of filling in different three-base overhang restric-
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tion enzyme cleavage sites (Bernstein and Baltimore, in 
preparation). These are the first well-defined mutants made 
by manipulating eDNA and then recovering virus after 
transfection. This particular method of mutagenesis was 
chosen partly because we suspected that small insertions 
would be more stable than point mutations given the high 
error rate of the RNA polymerase (10). Even so, variants of 
HF121 which have wild-type growth properties do arise. 
Presumably these are the product of second-site suppressor 
mutations. In fact, because of the tendency of HF121 to 
generate apparent revertants (there is no permissive growth 
condition under which selection for such variants can be 
minimized), mutant virus stocks are expanded from a pool of 
infectious foci. This is possible only because each infectious 
center obtained through expression of the eDNA clone is 
effectively a separate isolate of the virus. If such a mutant 
had been generated by conventional means, which is to say 
that it would have to be expanded from a single isolate, it 
might well have been lost due to overgrowth by apparent 
revertants. Other mutants have been obtained from other 
mutagenesis schemes and will be reported soon (P. Samow, 
K. Kirkegaard, and D. Baltimore, unpublished data). 
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